Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2024 Filed Dec 23, 2024 22:54 UTC |
Sundarrajan AlaguChief Information Officer
|
GrantRestricted Stock Units · Derivative | 16.62 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001383 · form4.xml · derivative · entry 1 Sundarrajan Alagu · CIK 0001848292 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,770.742 Underlying: Common Stock · 16.62 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:52 UTC |
Orth John EEVP, Operations
|
GrantRestricted Stock Units · Derivative | 55.733 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001381 · form4.xml · derivative · entry 3 Orth John E · CIK 0001764564 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,938.079 Underlying: Common Stock · 55.733 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:52 UTC |
Orth John EEVP, Operations
|
GrantRestricted Stock Units · Derivative | 37.989 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001381 · form4.xml · derivative · entry 2 Orth John E · CIK 0001764564 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,047.565 Underlying: Common Stock · 37.989 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:52 UTC |
Orth John EEVP, Operations
|
GrantRestricted Stock Units · Derivative | 16.62 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001381 · form4.xml · derivative · entry 1 Orth John E · CIK 0001764564 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,770.742 Underlying: Common Stock · 16.62 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:50 UTC |
Claussen James JExecutive Vice President & CFO
|
GrantRestricted Stock Units · Derivative | 111.465 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001379 · form4.xml · derivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,876.156 Underlying: Common Stock · 111.465 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:50 UTC |
Claussen James JExecutive Vice President & CFO
|
GrantRestricted Stock Units · Derivative | 75.978 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001379 · form4.xml · derivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,095.13 Underlying: Common Stock · 75.978 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:50 UTC |
Claussen James JExecutive Vice President & CFO
|
GrantRestricted Stock Units · Derivative | 38.779 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001379 · form4.xml · derivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,131.729 Underlying: Common Stock · 38.779 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:48 UTC |
Lehner Edward J.Director · President & CEO
|
GrantRestricted Stock Units · Derivative | 350.317 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001377 · form4.xml · derivative · entry 3 Lehner Edward J. · CIK 0001614103 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,325.053 Underlying: Common Stock · 350.317 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:48 UTC |
Lehner Edward J.Director · President & CEO
|
GrantRestricted Stock Units · Derivative | 238.786 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001377 · form4.xml · derivative · entry 2 Lehner Edward J. · CIK 0001614103 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,441.838 Underlying: Common Stock · 238.786 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. Read SEC document |
| December 19, 2024 Filed Dec 23, 2024 22:48 UTC |
Lehner Edward J.Director · President & CEO
|
GrantRestricted Stock Units · Derivative | 121.876 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-24-001377 · form4.xml · derivative · entry 1 Lehner Edward J. · CIK 0001614103 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,985.432 Underlying: Common Stock · 121.876 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of December 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 23:16 UTC |
Silver Mark S.EVP, GC & CHRO
|
SaleCommon Stock (par value $0.01 per share) | 9,000 | $24.56 | $221,040.00 |
DisclosureSEC source: 0001627959-24-000001 · primary_doc.xml · nonDerivative · entry 1 Silver Mark S. · CIK 0001627959 · EVP, GC & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,664 F1 · price: These shares were sold in multiple transactions at prices between $24.29 and $24.90. The reporting person undertakes to provide Ryerson Holding Corporation, any security holder of Ryerson Holding Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:16 UTC |
Kannan Molly DCAO & Corporate Controller
|
SaleCommon Stock (par value $0.01 per share) | 4,344 | $26.05 | $113,161.20 |
DisclosureSEC source: 0001799091-24-000001 · primary_doc.xml · nonDerivative · entry 1 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,180.4636 F1 · price: These shares were sold in multiple transactions at the price of $26.05. The reporting person undertakes to provide Ryerson Holding Corporation, any security holder of Ryerson Holding Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 01:46 UTC |
Leggio Karen MarieDirector
|
GrantCommon Stock (par value $0.01 per share) | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111085 · ownership.xml · nonDerivative · entry 1 Leggio Karen Marie · CIK 0002021777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 769 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 01:54 UTC |
Kumbier MichelleDirector
|
GrantCommon Stock (par value $0.01 per share) | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111092 · ownership.xml · nonDerivative · entry 1 Kumbier Michelle · CIK 0001640036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 769 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 01:51 UTC |
CARRUTHERS COURT DDirector
|
GrantCommon Stock (par value $0.01 per share) | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111090 · ownership.xml · nonDerivative · entry 1 CARRUTHERS COURT D · CIK 0001422164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,700 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 01:48 UTC |
Larson Stephen P.Director
|
GrantCommon Stock (par value $0.01 per share) | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111088 · ownership.xml · nonDerivative · entry 1 Larson Stephen P. · CIK 0001624556 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,700 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 01:47 UTC |
CALHOUN KIRK KDirector
|
GrantCommon Stock (par value $0.01 per share) | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-111087 · ownership.xml · nonDerivative · entry 1 CALHOUN KIRK K · CIK 0001203721 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,200 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| October 01, 2024 Filed Jan 3, 2025 21:28 UTC Amendment |
Leggio Karen MarieDirector
|
GrantCommon Stock (par value $0.01 per share) | 439 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-25-000017 · form4.xml · nonDerivative · entry 1 Leggio Karen Marie · CIK 0002021777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. F2 · balance_after: This amendment is being filed to correct an error in the number of securities beneficially owned by the Reporting Person following the acquisitions reported on October 1, 2024. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:24 UTC |
Kannan Molly DCAO & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 53.757 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108766 · ownership.xml · derivative · entry 3 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,882.346 Underlying: Common Stock · 53.757 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:24 UTC |
Kannan Molly DCAO & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 36.642 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108766 · ownership.xml · derivative · entry 2 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,009.576 Underlying: Common Stock · 36.642 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:24 UTC |
Kannan Molly DCAO & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 16.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108766 · ownership.xml · derivative · entry 1 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,754.122 Underlying: Common Stock · 16.031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 16:29 UTC |
Burbach MichaelChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 76.795 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108773 · ownership.xml · derivative · entry 3 Burbach Michael · CIK 0001628783 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,403.349 Underlying: Common Stock · 76.795 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 16:29 UTC |
Burbach MichaelChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 73.284 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108773 · ownership.xml · derivative · entry 2 Burbach Michael · CIK 0001628783 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,019.152 Underlying: Common Stock · 73.284 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 16:29 UTC |
Burbach MichaelChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 37.404 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108773 · ownership.xml · derivative · entry 1 Burbach Michael · CIK 0001628783 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,092.95 Underlying: Common Stock · 37.404 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:23 UTC |
Silver Mark S.EVP, GC & Chief HR Officer
|
GrantRestricted Stock Units · Derivative | 76.795 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108764 · ownership.xml · derivative · entry 3 Silver Mark S. · CIK 0001627959 · EVP, GC & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,403.349 Underlying: Common Stock · 76.795 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:23 UTC |
Silver Mark S.EVP, GC & Chief HR Officer
|
GrantRestricted Stock Units · Derivative | 52.346 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108764 · ownership.xml · derivative · entry 2 Silver Mark S. · CIK 0001627959 · EVP, GC & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,727.966 Underlying: Common Stock · 52.346 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:23 UTC |
Silver Mark S.EVP, GC & Chief HR Officer
|
GrantRestricted Stock Units · Derivative | 24.046 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108764 · ownership.xml · derivative · entry 1 Silver Mark S. · CIK 0001627959 · EVP, GC & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,631.183 Underlying: Common Stock · 24.046 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:33 UTC |
Orth John EEVP, Operations
|
GrantRestricted Stock Units · Derivative | 53.757 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108779 · ownership.xml · derivative · entry 3 Orth John E · CIK 0001764564 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,882.346 Underlying: Common Stock · 53.757 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:33 UTC |
Orth John EEVP, Operations
|
GrantRestricted Stock Units · Derivative | 36.642 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108779 · ownership.xml · derivative · entry 2 Orth John E · CIK 0001764564 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,009.576 Underlying: Common Stock · 36.642 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:33 UTC |
Orth John EEVP, Operations
|
GrantRestricted Stock Units · Derivative | 16.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108779 · ownership.xml · derivative · entry 1 Orth John E · CIK 0001764564 · EVP, Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,754.122 Underlying: Common Stock · 16.031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:26 UTC |
Sundarrajan AlaguChief Information Officer
|
GrantRestricted Stock Units · Derivative | 53.757 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108770 · ownership.xml · derivative · entry 3 Sundarrajan Alagu · CIK 0001848292 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,882.346 Underlying: Common Stock · 53.757 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:26 UTC |
Sundarrajan AlaguChief Information Officer
|
GrantRestricted Stock Units · Derivative | 36.642 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108770 · ownership.xml · derivative · entry 2 Sundarrajan Alagu · CIK 0001848292 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,009.576 Underlying: Common Stock · 36.642 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:26 UTC |
Sundarrajan AlaguChief Information Officer
|
GrantRestricted Stock Units · Derivative | 16.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108770 · ownership.xml · derivative · entry 1 Sundarrajan Alagu · CIK 0001848292 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,754.122 Underlying: Common Stock · 16.031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:29 UTC |
Lehner Edward J.Director · President & CEO
|
GrantRestricted Stock Units · Derivative | 337.896 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108774 · ownership.xml · derivative · entry 3 Lehner Edward J. · CIK 0001614103 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,974.736 Underlying: Common Stock · 337.896 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:29 UTC |
Lehner Edward J.Director · President & CEO
|
GrantRestricted Stock Units · Derivative | 230.32 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108774 · ownership.xml · derivative · entry 2 Lehner Edward J. · CIK 0001614103 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,203.052 Underlying: Common Stock · 230.32 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:29 UTC |
Lehner Edward J.Director · President & CEO
|
GrantRestricted Stock Units · Derivative | 117.555 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108774 · ownership.xml · derivative · entry 1 Lehner Edward J. · CIK 0001614103 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,863.556 Underlying: Common Stock · 117.555 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:25 UTC |
Claussen James JExecutive Vice President & CFO
|
GrantRestricted Stock Units · Derivative | 107.513 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108767 · ownership.xml · derivative · entry 3 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,764.691 Underlying: Common Stock · 107.513 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:25 UTC |
Claussen James JExecutive Vice President & CFO
|
GrantRestricted Stock Units · Derivative | 73.284 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108767 · ownership.xml · derivative · entry 2 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,019.152 Underlying: Common Stock · 73.284 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| September 19, 2024 Filed Sep 23, 2024 20:25 UTC |
Claussen James JExecutive Vice President & CFO
|
GrantRestricted Stock Units · Derivative | 37.404 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-108767 · ownership.xml · derivative · entry 1 Claussen James J · CIK 0001841035 · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,092.95 Underlying: Common Stock · 37.404 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F6 · shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of September 19, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F6 · derivative.underlying_shares: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. F6 · balance_after: The number of dividend equivalent rights reported on this Form 4 have been shown to the third decimal place. This reflects a change in the reporting methodology. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:16 UTC |
Leggio Karen MarieDirector
|
GrantCommon Stock (par value $0.01 per share) | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080946 · ownership.xml · nonDerivative · entry 1 Leggio Karen Marie · CIK 0002021777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:18 UTC |
CALHOUN KIRK KDirector
|
GrantCommon Stock (par value $0.01 per share) | 448 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080949 · ownership.xml · nonDerivative · entry 1 CALHOUN KIRK K · CIK 0001203721 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,761 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:14 UTC |
Larson Stephen P.Director
|
GrantCommon Stock (par value $0.01 per share) | 448 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080942 · ownership.xml · nonDerivative · entry 1 Larson Stephen P. · CIK 0001624556 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,261 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:11 UTC |
Kumbier MichelleDirector
|
GrantCommon Stock (par value $0.01 per share) | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080938 · ownership.xml · nonDerivative · entry 1 Kumbier Michelle · CIK 0001640036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 23:10 UTC |
CARRUTHERS COURT DDirector
|
GrantCommon Stock (par value $0.01 per share) | 448 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080937 · ownership.xml · nonDerivative · entry 1 CARRUTHERS COURT D · CIK 0001422164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,261 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. Read SEC document |
| July 01, 2024 Filed Jan 3, 2025 21:27 UTC Amendment |
Leggio Karen MarieDirector
|
GrantCommon Stock (par value ($0.01 per share) | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0000899140-25-000016 · form4.xml · nonDerivative · entry 1 Leggio Karen Marie · CIK 0002021777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,457 F1 · shares: Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date. F2 · balance_after: This amendment is being filed to correct an error in the number of securities beneficially owned by the Reporting Person following the acquisitions reported on July 2, 2024. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:26 UTC |
Kannan Molly DCAO & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 53.5884 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076752 · ownership.xml · derivative · entry 3 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,828.5884 Underlying: Common Stock · 53.5884 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:26 UTC |
Kannan Molly DCAO & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 36.5272 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076752 · ownership.xml · derivative · entry 2 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,972.9346 Underlying: Common Stock · 36.5272 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:26 UTC |
Kannan Molly DCAO & Corporate Controller
|
GrantRestricted Stock Units · Derivative | 15.9803 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076752 · ownership.xml · derivative · entry 1 Kannan Molly D · CIK 0001799091 · CAO & Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,738.0909 Underlying: Common Stock · 15.9803 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F3 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2022 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 16:26 UTC |
Burbach MichaelChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 76.5549 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076753 · ownership.xml · derivative · entry 3 Burbach Michael · CIK 0001628783 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,326.5549 Underlying: Common Stock · 76.5549 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F5 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. F5 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2024 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025, March 31, 2026 and March 31, 2027. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 16:26 UTC |
Burbach MichaelChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 73.0542 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-076753 · ownership.xml · derivative · entry 2 Burbach Michael · CIK 0001628783 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,945.8684 Underlying: Common Stock · 73.0542 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of Ryerson Holding Corporation (the "Company"). F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted stock units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. F4 · derivative.exercise_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. F4 · derivative.expiration_date: The dividend equivalent rights accrued on restricted stock units that were granted on March 31, 2023 and outstanding as of June 20, 2024. These unvested restricted stock units, and the dividend equivalent rights related to such unvested restricted stock units, will vest on March 31, 2025 and March 31, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.